| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |